Please be advised that to ensure the safety of myself and clients that I will not be accepting clients who have taken the experimental mRNA Covid injection within 21 days of their appointment.

This decision is based on the fact that the manufacturers have not accepted any financial liability for compensating any adverse events of their mRNA Covid injections, in fact in New Zealand they have been granted indemnity by the government. In New Zealand the injection has only been given provisional approval by MedSafe with 58 provisions. Furthermore, I have taken into account the lack of animal trials (especially long term safety studies), lack of long-term human trials and a lack of comprehensive trials which include a true representation of the population (not just the healthy) as well as lack of reporting the effects of the injection on human reproduction. Many of these concerns are shared by MedSafe in their Summery of Risk Management for the Covid injection.  I am also aware of past animal trials in 2012 with MDNA injection technology where animals suffered from pulmonary immunopathology on the challenge with the SARS virus. Finally, considering worldwide vaccine adverse reaction reporting systems such as this one which according to this government report (page 6, third paragraph) only represent 1% of the actual numbers and yet already show alarming rates of adverse reactions.

The purpose of this policy is for protection of possible spike protein viral shedding (which according to this study impairs endothelial function via downregulation of ACE 2) prevent overall transmission from injected persons to non injected persons according to this Pfizer document (bottom of page 67) and also to prevent possible contraindications in treatments with the possible negative side effects of the experimental injection. A new article explaining spike proteins and possible reasons for so many of the following side effects including links to studies, can be found here. Reported side effects that are of concern include and are not limited to; flu symptoms, miscarriages, still births, infertility, seizures, blood clotting disorders, autoimmune disorders, neurological damage, prion disease, encephalitis, brain damage, Bell’s Palsy, myocarditis and pericarditis (according to this FDA document page 7) and death. These effects and more can be found in this FDA document on page 17 already in October 2020.

I apologise for any inconvenience and we will re-evaluate our policy when clinical trials of the experimental injections are completed in 2023 (see Pfizer study with beginning date April 29th, 2020 to completion date May 2nd, 2023) or when new information comes to light. 

Thank you for your understanding.